{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:31:07Z","timestamp":1786714267714,"version":"build-2736575974"},"reference-count":43,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"unspecified","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Young Program of National Natural Science Funds","award":["82200726"],"award-info":[{"award-number":["82200726"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,8,4]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Tumor-derived lactate has long been regarded as a metabolic waste product. However, accumulating evidence indicates that lactate also functions as a signaling molecule that actively remodels the tumor immune microenvironment. How lactate-driven post-translational modifications in immune cells contribute to immune evasion in hepatocellular carcinoma (HCC) remains incompletely understood. This study aimed to identify the immune cell population responsible for lactylation-driven immunosuppression in HCC and to elucidate the molecular mechanism by which lactylation rewires macrophage metabolism to impair CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell-mediated antitumor immunity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Selective in vivo immune cell depletion models were employed to define the key immune mediators of lactate-induced immunosuppression. Proteomic screening, site-directed mutagenesis, and lipidomic profiling were used to characterize lactylation targets and lipid metabolic alterations. Functional assays, including signaling pathway analyses, cytokine measurements, and tumor immune profiling, were performed in both in vitro systems and mouse HCC models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Macrophages were identified as the principal immune cell type mediating lactylation-dependent immunosuppression in HCC. Alanyl-tRNA synthetase 1 (AARS1) functioned as a non-canonical lactyltransferase, catalyzing lactylation of carnitine palmitoyltransferase 1A at lysine 675. This modification impaired long-chain fatty acid transport into mitochondria, leading to cytosolic accumulation of oleic acid (OA). OA directly disrupted cGAS binding to cytosolic DNA, thereby suppressing STING activation and type I interferon (IFN-I) production. Attenuated IFN-I signaling resulted in reduced major histocompatibility complex-I expression on tumor cells and impaired CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell-mediated recognition and cytotoxicity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings uncover a lactate-lipid metabolism axis that links tumor-derived lactate to innate immune suppression in HCC. Targeting AARS1-mediated lactylation represents a potential therapeutic strategy to restore macrophage immunostimulatory function and enhance antitumor immunity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2026-015773","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T12:45:22Z","timestamp":1786711522000},"page":"e015773","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["AARS1-mediated lactylation reprograms macrophage lipid metabolism to restrict antitumor immunity"],"prefix":"10.1136","volume":"14","author":[{"given":"Zhaofeng","family":"Xiao","sequence":"first","affiliation":[{"name":"Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Meng","sequence":"additional","affiliation":[{"name":"Zhejiang Key Laboratory of Zero Magnetic Medicine, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, China"},{"name":"Institute of Organ Transplantation, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Xu","sequence":"additional","affiliation":[{"name":"Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Wang","sequence":"additional","affiliation":[{"name":"General Surgery, Cancer Center, Department of Hepatobiliary and Pancreatic Surgery and Minimally Invasive Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2576-8764","authenticated-orcid":false,"given":"Jinyi","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongda","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1625-6478","authenticated-orcid":false,"given":"Xiaodong","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, Liaoning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"2026081405451643000_14.8.e015773.1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411471","article-title":"Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression","volume":"24","author":"Kotsari","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026081405451643000_14.8.e015773.2","doi-asserted-by":"crossref","first-page":"216038","DOI":"10.1016\/j.canlet.2022.216038","article-title":"Immune checkpoint inhibitor resistance in hepatocellular carcinoma","volume":"555","author":"Wang","year":"2023","journal-title":"Cancer Lett"},{"key":"2026081405451643000_14.8.e015773.3","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/cac2.12345","article-title":"Tumor-associated macrophages in liver cancer: From mechanisms to therapy","volume":"42","author":"Cheng","year":"2022","journal-title":"Cancer Commun (Lond)"},{"key":"2026081405451643000_14.8.e015773.4","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-020-00916-z","article-title":"cGAS-STING, an important pathway in cancer immunotherapy","volume":"13","author":"Jiang","year":"2020","journal-title":"J Hematol Oncol"},{"key":"2026081405451643000_14.8.e015773.5","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-025-01691-5","article-title":"The cGAS\u2012STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications","volume":"18","author":"Shen","year":"2025","journal-title":"J Hematol Oncol"},{"key":"2026081405451643000_14.8.e015773.6","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-024-05191-6","article-title":"cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors","volume":"81","author":"Li","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"2026081405451643000_14.8.e015773.7","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-022-04219-z","article-title":"Type I interferon-mediated tumor immunity and its role in immunotherapy","volume":"79","author":"Yu","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"2026081405451643000_14.8.e015773.8","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000005"},{"key":"2026081405451643000_14.8.e015773.9","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/HEP.0000000000000025","article-title":"SULT2B1-CS-DOCK2 axis regulates effector T-cell exhaustion in HCC microenvironment","volume":"78","author":"Wang","year":"2023","journal-title":"Hepatology"},{"key":"2026081405451643000_14.8.e015773.10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103627","article-title":"Lactate in the tumour microenvironment: From immune modulation to therapy","volume":"73","author":"Wang","year":"2021","journal-title":"EBioMedicine"},{"key":"2026081405451643000_14.8.e015773.11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911943","article-title":"Lactate-Lactylation Hands between Metabolic Reprogramming and Immunosuppression","volume":"23","author":"Chen","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026081405451643000_14.8.e015773.12","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.1029218","article-title":"Aminoacyl-tRNA synthetases in human health and disease","volume":"13","author":"Turvey","year":"2022","journal-title":"Front Physiol"},{"key":"2026081405451643000_14.8.e015773.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07992-y"},{"key":"2026081405451643000_14.8.e015773.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.04.002"},{"key":"2026081405451643000_14.8.e015773.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01199-x"},{"key":"2026081405451643000_14.8.e015773.16","doi-asserted-by":"crossref","first-page":"113994","DOI":"10.1016\/j.yexcr.2024.113994","article-title":"ALKBH5-mediated upregulation of CPT1A promotes macrophage fatty acid metabolism and M2 macrophage polarization, facilitating malignant progression of colorectal cancer","volume":"437","author":"Sun","year":"2024","journal-title":"Exp Cell Res"},{"key":"2026081405451643000_14.8.e015773.17","unstructured":"Xun Z . Integrating single-cell and spatial transcriptomics to elucidate the cross-talk of SPP1+ macrophage and cancer associated fibroblast in HCC with immune excluded microenvironment. Mendeley Data 2022. Available: https:\/\/doi.org\/10.17632\/skrx2fz79n.1"},{"key":"2026081405451643000_14.8.e015773.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0114-2"},{"key":"2026081405451643000_14.8.e015773.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107523"},{"key":"2026081405451643000_14.8.e015773.20","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/s43018-022-00444-4","article-title":"Silencing EGFR-upregulated expression of CD55 and CD59 activates the complement system and sensitizes lung cancer to checkpoint blockade","volume":"3","author":"Shao","year":"2022","journal-title":"Nat Cancer"},{"key":"2026081405451643000_14.8.e015773.21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/17425247.2021.1825376","article-title":"Platinum-based chemotherapy in combination with PD-1\/PD-L1 inhibitors: preclinical and clinical studies and mechanism of action","volume":"18","author":"Xue","year":"2021","journal-title":"Expert Opin Drug Deliv"},{"key":"2026081405451643000_14.8.e015773.22","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12530"},{"key":"2026081405451643000_14.8.e015773.23","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"2026081405451643000_14.8.e015773.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-024-01045-4"},{"key":"2026081405451643000_14.8.e015773.25","doi-asserted-by":"crossref","first-page":"217231","DOI":"10.1016\/j.canlet.2024.217231","article-title":"MATR3 promotes liver cancer progression by suppressing DHX58-mediated type I interferon response","volume":"604","author":"Xiao","year":"2024","journal-title":"Cancer Lett"},{"key":"2026081405451643000_14.8.e015773.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2022.08.006"},{"key":"2026081405451643000_14.8.e015773.27","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay8085","article-title":"Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense","volume":"370","author":"Bosch","year":"2020","journal-title":"Science"},{"key":"2026081405451643000_14.8.e015773.28","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202206820","article-title":"Oleic Acid Dissolves cGAS-DNA Phase Separation to Inhibit Immune Surveillance","volume":"10","author":"Wang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"2026081405451643000_14.8.e015773.29","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.1c00203"},{"key":"2026081405451643000_14.8.e015773.30","doi-asserted-by":"publisher","DOI":"10.1038\/nature13490"},{"key":"2026081405451643000_14.8.e015773.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113746"},{"key":"2026081405451643000_14.8.e015773.32","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi8602","article-title":"Lactate supports a metabolic-epigenetic link in macrophage polarization","volume":"7","author":"Noe","year":"2021","journal-title":"Sci Adv"},{"key":"2026081405451643000_14.8.e015773.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2024.04.006"},{"key":"2026081405451643000_14.8.e015773.34","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-33349-y","article-title":"CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis","volume":"13","author":"Yang","year":"2022","journal-title":"Nat Commun"},{"key":"2026081405451643000_14.8.e015773.35","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-19-0261"},{"key":"2026081405451643000_14.8.e015773.36","doi-asserted-by":"publisher","DOI":"10.24272\/J.ISSN.2095-8137.2022.464"},{"key":"2026081405451643000_14.8.e015773.37","doi-asserted-by":"crossref","DOI":"10.3390\/cells11193043","article-title":"Post-Translational Modifications of cGAS-STING: A Critical Switch for Immune Regulation","volume":"11","author":"Yu","year":"2022","journal-title":"Cells"},{"key":"2026081405451643000_14.8.e015773.38","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1016\/j.immuni.2023.10.015","article-title":"SMPDL3A links cholesterol metabolism to the cGAS-STING pathway","volume":"56","author":"Shin","year":"2023","journal-title":"Immunity"},{"key":"2026081405451643000_14.8.e015773.39","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-43381-1","article-title":"PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma","volume":"14","author":"Cappuyns","year":"2023","journal-title":"Nat Commun"},{"key":"2026081405451643000_14.8.e015773.40","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-59529-0","article-title":"SPP1\u2009+ macrophages cause exhaustion of tumor-specific T cells in liver metastases","volume":"16","author":"Trehan","year":"2025","journal-title":"Nat Commun"},{"key":"2026081405451643000_14.8.e015773.41","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-024-02212-7","article-title":"Resistance mechanisms to immune checkpoint inhibitors: updated insights","volume":"24","author":"Alsaafeen","year":"2025","journal-title":"Mol Cancer"},{"key":"2026081405451643000_14.8.e015773.42","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-024-01765-9","article-title":"Harnessing innate immune pathways for therapeutic advancement in cancer","volume":"9","author":"Hu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"2026081405451643000_14.8.e015773.43","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-024-01807-9","article-title":"Fatty acid metabolism of immune cells: a new target of tumour immunotherapy","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death Discov"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2026-015773","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T12:45:26Z","timestamp":1786711526000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2026-015773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":43,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,14]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/jitc-2026-015773"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2026-015773","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}